# Fennec Pharmaceuticals (FENC) — Earnings

FENC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/fenc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.05 |
| EPS estimate | $0.02 |
| EPS surprise | +150.00% |
| Revenue surprise | +10.29% |
| Revenue | $17.9M |
| Revenue estimate | $16.2M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1211583/000110465926095884/fencf-20260630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/fd9d4822-e56a-2aef-73ba-3381519f05b5.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | $0.02 | $0.05 | 150.00% | $16.2M | $17.9M |
| Q1 2026 | May 14, 2026 | −$0.04 | $0.01 | 122.78% | $13.9M | $15.1M |
| Q4 2025 | Mar 24, 2026 | $0.04 | −$0.17 | -504.76% | $14.7M | $13.8M |
| Q3 2025 | Nov 13, 2025 | −$0.02 | −$0.02 | 9.05% | $11.2M | $12.6M |
| Q2 2025 | Aug 14, 2025 | −$0.03 | −$0.11 | -219.20% | $9.6M | $9.8M |
| Q1 2025 | May 14, 2025 | −$0.09 | −$0.04 | 55.90% | $8.1M | $8.5M |
| Q4 2024 | Mar 10, 2025 | −$0.13 | −$0.06 | 53.19% | $7.8M | $7.9M |
| Q3 2024 | Nov 8, 2024 | −$0.09 | −$0.22 | -136.48% | $9.1M | $7.1M |
| Q2 2024 | Aug 13, 2024 | −$0.02 | −$0.20 | -718.78% | $11.1M | $7.3M |
| Q1 2024 | May 14, 2024 | −$0.06 | $0.41 | 818.26% | $10.2M | $25.6M |
| Q4 2023 | Mar 25, 2024 | −$0.02 | −$0.10 | -454.89% | $8.9M | $9.9M |
| Q3 2023 | Nov 7, 2023 | −$0.12 | −$0.07 | 40.61% | $5.3M | $6.5M |
| Q2 2023 | Aug 4, 2023 | −$0.16 | −$0.21 | -33.80% | $3.8M | $3.4M |
| Q1 2023 | May 12, 2023 | −$0.20 | −$0.23 | -13.41% | $1.8M | $1.7M |
| Q3 2022 | Nov 14, 2022 | −$0.18 | −$0.30 | -67.06% | — | — |
| Q2 2022 | Aug 12, 2022 | −$0.14 | −$0.19 | -39.64% | — | — |
| Q1 2022 | May 12, 2022 | −$0.14 | −$0.15 | -1.46% | — | — |
| Q4 2021 | Feb 28, 2022 | $0.76 | −$0.18 | -123.88% | $50.6M | — |
| Q3 2021 | Nov 10, 2021 | −$0.17 | −$0.16 | 6.50% | — | — |
| Q2 2021 | Aug 10, 2021 | −$0.19 | −$0.15 | 18.66% | — | — |

## Frequently Asked Questions

### When did Fennec Pharmaceuticals (FENC) last report earnings?

Fennec Pharmaceuticals last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did FENC beat earnings estimates?

Yes. Fennec Pharmaceuticals reported EPS of $0.05 for Q2 2026 against a $0.02 estimate — a 150.00% beat.

### How much revenue did FENC report last quarter?

Fennec Pharmaceuticals reported $17.9M in revenue for Q2 2026, against a consensus estimate of $16.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).